Lemay Virginia, Whalen Audrey, Cohen Lisa, Bratberg Jeffrey
J Am Pharm Assoc (2003). 2025 Jan-Feb;65(1):102259. doi: 10.1016/j.japh.2024.102259. Epub 2024 Oct 3.
Increasing convenient, accessible, and cost effective contraceptive access is critically important. Two-thirds of U.S. states permit pharmacists to prescribe hormonal contraceptives. Community pharmacies are ideal settings for patients to be offered contraceptive therapeutic options, including hormonal contraceptives, emergency contraception (EC), and over-the-counter (OTC) oral contraception.
The objective of this study was to assess college student and community pharmacy patients' perspectives on pharmacist-prescribed hormonal contraceptives, likelihood of accessing contraceptives from a pharmacist, and perspectives regarding EC and OTC oral contraception.
The researchers conducted an observational study distributed to college students and patients accessing care at community-based pharmacies from October 2022 to February 2023. The survey population included those who were 18 years or older, English speaking, and recruited both in person and online. Survey questions assessed barriers to contraception access, perspectives toward pharmacist-prescribed hormonal contraception, likelihood of receiving pharmacist-prescribed hormonal contraception, as well as EC and OTC oral contraception at the community pharmacy. Results from the pharmacist and clinician surveys were previously published, therefore this report will focus on the student and patient data.
Ninety-one percent of all respondents strongly agreed or agreed with pharmacist-prescribed hormonal contraception. Students and patients reported convenience, time-saving, and money saving as reasons for obtaining from their pharmacist. In regard to EC, 36% reported having ever purchased from a pharmacy and 58% were extremely or somewhat likely to purchase OTC oral contraception.
The majority of students and community pharmacy patients surveyed in Rhode Island support pharmacist-prescribed hormonal contraceptives. State-level policy advancements with reimbursement for services provide pharmacists an opportunity to provide contraceptive care for all people.
增加方便、可及且具成本效益的避孕途径至关重要。美国三分之二的州允许药剂师开具激素避孕药。社区药房是为患者提供避孕治疗选择的理想场所，这些选择包括激素避孕药、紧急避孕（EC）和非处方（OTC）口服避孕药。
本研究的目的是评估大学生和社区药房患者对药剂师开具的激素避孕药的看法、从药剂师处获取避孕药的可能性，以及对紧急避孕和非处方口服避孕药的看法。
研究人员于2022年10月至2023年2月对大学生和在社区药房就诊的患者进行了一项观察性研究。调查对象包括18岁及以上、说英语、通过线下和线上招募的人群。调查问题评估了避孕途径的障碍、对药剂师开具的激素避孕的看法、接受药剂师开具的激素避孕的可能性，以及在社区药房获取紧急避孕和非处方口服避孕药的情况。药剂师和临床医生的调查结果此前已发表，因此本报告将聚焦于学生和患者的数据。
91%的受访者强烈同意或同意药剂师开具激素避孕药。学生和患者表示，方便、省时和省钱是从药剂师处获取避孕药的原因。关于紧急避孕，36%的受访者表示曾从药房购买过，58%的受访者极有可能或有可能购买非处方口服避孕药。
在罗德岛接受调查的大多数学生和社区药房患者支持药剂师开具的激素避孕药。州一级有关服务报销的政策进步为药剂师提供了为所有人提供避孕护理的机会。
